期刊文献+

非小细胞肺癌患者经皮微波消融术后肿瘤相关性死亡危险因素 被引量:5

Risk factors of tumor related death in patients with non-small cell lung cancer after percutaneous microwave ablation
下载PDF
导出
摘要 目的探讨经皮微波消融术后的非小细胞肺癌患者发生肿瘤相关性死亡的危险因素。方法回顾研究在我科行经皮微波消融术的70例非小细胞肺癌患者,对其年龄、性别、肿瘤分期等一般因素进行单因素、Logistic分析,以期发现肿瘤相关性死亡的危险因素。结果单因素分析示,瘤直径<3 cm与≥3 cm患者的生存率分别为81.8%(9/11)、40.7%(24/59),接受辅助治疗与非接受辅助治疗患者的生存率分别为58.3%(21/36)、29.4%(10/34),差异有统计学意义(P<0.05)。多因素分析示,非小细胞肺癌患者微波消融术后肿瘤相关性死亡的重要危险因素为肿瘤分期、肿瘤直径与术后辅助治疗(均P<0.05)。结论正确掌握肿瘤分期、直径的大小、积极的术后辅助治疗能减少患者经皮微波消融术后肿瘤相关性死亡的风险。 Objective To investigate the risk factors of tumor related death in patients with non-small cell lung cancer after percutaneous microwave ablation.Methods A retrospective analysis of 70 cases of non-small cell lung cancer patients undergoing percutaneous microwave ablation was conducted.Single factor and logistic anal-ysis were performed for the risk factors of tumor related death.Results The single factor analysis showed that sur-vival rate of patients with tumor diameter<3 cm and≥3 cm was 81.8%(9/11)and 40.7%(24/59)respectively and that of patients receiving adjuvant treatment and those receiving no adjuvant treatment was 58.3%(21/36),and 29.4%(10/34)respectively and the differences were statistically significant(P<0.05).Multivariate analysis showed that the important risk factors of tumor related death after percutaneous microwave ablation were tumor stage,tumor diameter and postoperative adjuvant treatment(all P<0.05).Conclusion Cancer staging,diame-ter,and positive postoperative adjuvant therapy can reduce the risk of tumor related death after percutaneous micro-wave ablation.
作者 庞敏 盛立军 宿超 宋鹏远 安玉姬 何伟娜 张卫华 张亚非 PANG Min;SHENG Lijun;SU Chao;SONG Pengyuan;AN Yuji;HE Weina;ZHANG Weihua;ZHANG Yafei(Department of Internal Medicine,Affiliated Hospital of Shandong Medical Science Academy,Jinan 250000,China)
出处 《实用医学杂志》 CAS 北大核心 2018年第13期2108-2110,2114,共4页 The Journal of Practical Medicine
基金 山东省医学科学院院级科技计划青年项目(编号:2016-43)
关键词 非小细胞肺癌 微波消融术 肿瘤相关性死亡 non-small cell lung cancer microwave ablation tumor related death
  • 相关文献

参考文献7

二级参考文献43

  • 1陈理明,李晓洁,蔡应木,王少彬,陈俊辉.肝癌肺癌患者射频消融治疗后细胞免疫功能变化[J].实用医学杂志,2006,22(21):2467-2468. 被引量:11
  • 2李慎江,肖湘生,刘士远,刘惠民,李玉莉,李惠民,李成洲,张沉石,陶志伟,杨春山,姜庆军,欧阳林,于红.明显强化孤立肺结节血流模式的临床价值[J].中华放射学杂志,2004,38(10):1062-1068. 被引量:62
  • 3朱良明,李前生,蔺玉霞,肖伟.经皮微波热凝固疗法治疗周围型肺癌的近期疗效评价(附16例报告)[J].中国微创外科杂志,2006,6(2):115-116. 被引量:16
  • 4何文,胡向东,邬冬芳,郭莉.超声引导经皮穿刺微波消融治疗肺癌[J].中国微创外科杂志,2007,7(5):406-408. 被引量:18
  • 5Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008 [J]. Int J Cancer, 2010, 127 (12):2893-2917.
  • 6Parkin DM, Bray FB, Pisani P. Global cancer statistics[J]. CA Cancer J Clin, 2005,55 (2):74-108.
  • 7卫生部肿瘤消融治疗技术管理规范[M].2009.
  • 8Eisenhauer EA, Therasse P, Bogaerts J. New response evaluation criteria in solid tumours:revised RECIST guideline (version 1.1) [J]. European Journal of Cancer, 2009,45 (2):228.
  • 9Bun-is HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial [J]. J Clin Oncol, 1997,15:2403-2413.
  • 10Sheth S. Current and emerging therapies for patients with advanced non-small-cell lung cancer [J]. Am J Health Syst Pharm, 2010,67(1 Suppl 1):S9-14.

共引文献73

同被引文献55

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部